tiprankstipranks
Xeris Pharmaceuticals (XERS)
:XERS
US Market

Xeris Pharmaceuticals (XERS) Financial Statements

Compare
973 Followers

Xeris Pharmaceuticals Financial Overview

Xeris Pharmaceuticals's market cap is currently $866.68M. The company's EPS TTM is $-0.376; its P/E ratio is ―; Xeris Pharmaceuticals is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 203.07M$ 163.91M$ 110.25M$ 110.25M$ 49.59M
Gross Profit$ 166.24M$ 135.27M$ 87.61M$ 87.61M$ 36.27M
Operating Income$ -33.65M$ -44.01M$ -81.94M$ -81.94M$ -115.16M
EBITDA$ -13.99M$ -23.73M$ -69.31M$ -113.67M$ -80.08M
Net Income$ -54.84M$ -62.26M$ -94.66M$ -94.66M$ -122.72M
Balance Sheet
Cash & Short-Term Investments$ 71.62M$ 72.45M$ 121.97M$ 121.97M$ 102.43M
Total Assets$ 323.06M$ 322.60M$ 344.52M$ 344.52M$ 304.36M
Total Debt$ 271.45M$ 229.19M$ 198.06M$ 198.06M$ 88.07M
Net Debt$ 199.83M$ 161.74M$ 76.09M$ 76.09M$ 20.80M
Total Liabilities$ 352.68M$ 329.38M$ 299.33M$ 299.33M$ 209.13M
Stockholders' Equity$ -29.61M$ -6.78M$ 45.19M$ 45.19M$ 95.23M
Cash Flow
Free Cash Flow$ -37.85M$ -49.29M$ -103.42M$ -103.42M$ -96.62M
Operating Cash Flow$ -36.98M$ -47.02M$ -102.89M$ -102.89M$ -95.53M
Investing Cash Flow$ 4.88M$ -6.00M$ 34.46M$ 34.46M$ 97.96M
Financing Cash Flow$ 36.17M$ -1.61M$ 127.47M$ 127.47M$ 27.25M
Currency in USD

Xeris Pharmaceuticals Earnings and Revenue History

Xeris Pharmaceuticals Debt to Assets

Xeris Pharmaceuticals Cash Flow

Xeris Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis